Home › NDC Lookup › RxCUI directory › RxCUI 597406

Meloxicam 1.5 MG/ML Oral Suspension — RxCUI 597406

RxNorm drug concept · Semantic clinical drug
RxCUI 597406 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI597406
Official nameMeloxicam 1.5 MG/ML Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmeloxicam 7.5 MG per 5 ML Oral Suspension; meloxicam 7.5 MG in 5 mL Oral Suspension
FDA products mapped3
Package NDCs mapped3
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Meloxicam: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Meloxicam is primarily used to relieve pain and inflammation caused by osteoarthritis, rheumatoid arthritis, and juvenile rheumatoid arthritis in kids. There are also two IV versio...
  • What exactly is meloxicam used for — is it just for arthritis?
  • Good news — you can take oral meloxicam with or without food, so it fits into your routine however works best for you. If your stomach tends to be sensitive, taking it with a littl...
  • Should I take meloxicam with food, or does it not matter?
📖 Read our full Meloxicam guide →

🕸️ Concept Web — How Meloxicam 1.5 MG/ML Oral Suspension Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Meloxicam 1.5 MG/ML Oral Suspension RxCUI 597406

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Meloxicam 41493
  2. Brand names 5

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Loxicom 1364057
    • Meloxidyl 1439977
    • Metacam 1086708
    • Ostilox 1482670
    • Zybic 2730291
  3. Dose forms 21

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Meloxicam Oral Suspension 597405
    • Meloxicam Oral Liquid Product 1165107
    • Meloxicam Oral Product 1165678
    • Meloxicam Oral Suspension [Loxicom] 1648916
    • Meloxicam Oral Suspension [Meloxidyl] 1439979
    • Meloxicam Oral Suspension [Metacam] 1091878
    • Meloxicam Oral Suspension [Ostilox] 1649011
    • Meloxicam Oral Suspension [Zybic] 2730295
    • +13 more in this family
  4. Clinical & branded drugs 11

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Meloxicam 1.5 MG/ML 597404
    • Meloxicam 1.5 MG/ML Oral Suspension [Loxicom] 1648919
    • Meloxicam 1.5 MG/ML Oral Suspension [Meloxidyl] 1439982
    • Meloxicam 1.5 MG/ML Oral Suspension [Metacam] 1092195
    • Meloxicam 1.5 MG/ML Oral Suspension [Ostilox] 1649014
    • Meloxicam 1.5 MG/ML Oral Suspension [Zybic] 2730296
    • Meloxicam 1.5 MG/ML [Loxicom] 1648915
    • Meloxicam 1.5 MG/ML [Meloxidyl] 1439978
    • +3 more in this family

Showing up to 8 concepts per family — 22 of 38 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Meloxicam 1.5 MG/ML SCDC · 597404
  • Meloxicam Oral Suspension SCDF · 597405
  • Meloxicam Oral Liquid Product SCDG · 1165107
  • Meloxicam Oral Product SCDG · 1165678

Brand-Name Concepts

  • Meloxicam 1.5 MG/ML Oral Suspension [Zybic] SBD · 2730296
  • Meloxicam 1.5 MG/ML Oral Suspension [Loxicom] SBD · 1648919
  • Meloxicam 1.5 MG/ML Oral Suspension [Meloxidyl] SBD · 1439982
  • Meloxicam 1.5 MG/ML Oral Suspension [Metacam] SBD · 1092195
  • Meloxicam 1.5 MG/ML Oral Suspension [Ostilox] SBD · 1649014
  • Meloxicam 1.5 MG/ML [Loxicom] SBDC · 1648915
  • Meloxicam 1.5 MG/ML [Meloxidyl] SBDC · 1439978
  • Meloxicam 1.5 MG/ML [Metacam] SBDC · 1092194
  • Meloxicam 1.5 MG/ML [Ostilox] SBDC · 1649010
  • Meloxicam 1.5 MG/ML [Zybic] SBDC · 2730292

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 597406 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
71740-0339-11 1 BOTTLE, PLASTIC in 1 CARTON (71740-339-11) / 100 mL in 1... Meloxicam Avondale Pharmaceuticals, LLC 2022-06-21
71741-0228-10 1 BOTTLE, PLASTIC in 1 CARTON (71741-228-10) / 100 mL in 1... Zybic Redmont Pharmaceuticals, LLC 2025-12-23
72919-0124-10 1 BOTTLE, PLASTIC in 1 CARTON (72919-124-10) / 100 mL in 1... Meloxicam Emerald Therapeutics, LLC 2022-06-29
Observed labelers: Avondale Pharmaceuticals, LLC (1) · Emerald Therapeutics, LLC (1) · Redmont Pharmaceuticals, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.